Stock 2070 SAUDI PHARMACEUTICAL INDUSTRIES AND MEDICAL APPLIANCES CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Ratings Saudi Pharmaceutical Industries and Medical Appliances Corporation

Equities

2070

SA0007879188

Delayed Saudi Arabian S.E.
Other stock markets
 06:26:52 2024-05-23 am EDT 		5-day change 1st Jan Change
34.3 SAR -0.44% Intraday chart for Saudi Pharmaceutical Industries and Medical Appliances Corporation -8.29% -9.26%
May. 21 Saudi Pharmaceutical Industries and Medical Appliances Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
May. 16 Saudi-based Spimaco Logs Lower Q1 Net Profit, Revenue MT

Summary

  • From a short-term investment perspective, the company presents a deteriorated fundamental configuration.

Strengths

  • The company's profit outlook over the next few years is a strong asset.
  • The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.

Weaknesses

  • The group shows a rather high level of debt in proportion to its EBITDA.
  • The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 46.6 times its estimated earnings per share for the ongoing year.
  • The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
  • For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
  • For the last few months, analysts have been revising downwards their earnings forecast.
  • Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.
  • Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.

Ratings chart - Surperformance

Sector: Pharmaceuticals

1st Jan change Capi. Investor Rating ESG Refinitiv
SAUDI PHARMACEUTICAL INDUSTRIES AND MEDICAL APPLIANCES CORPORATION Stock Saudi Pharmaceutical Industries and Medical Appliances Corporation
-9.26% 1.1B -
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+37.74% 723B
C+
NOVO NORDISK A/S Stock Novo Nordisk A/S
+34.71% 595B
B
JOHNSON & JOHNSON Stock Johnson & Johnson
-2.07% 369B
C+
MERCK & CO., INC. Stock Merck & Co., Inc.
+20.25% 332B
B-
ABBVIE INC. Stock AbbVie Inc.
+2.99% 282B
C+
ASTRAZENECA PLC Stock AstraZeneca PLC
+17.12% 244B
B+
NOVARTIS AG Stock Novartis AG
+9.99% 208B
B-
ROCHE HOLDING AG Stock Roche Holding AG
-4.05% 205B
A+
AMGEN INC. Stock Amgen Inc.
+7.43% 166B
C+
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
Yield

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion
-

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. 2070 Stock
  4. Ratings Saudi Pharmaceutical Industries and Medical Appliances Corporation